Bariatric surgery restores cardiac and sudomotor autonomic C-fiber dysfunction towards normal in obese subjects with type 2 diabetes

PLoS ONE

Volumn 11, Issue 5, 2016, Pages

  Casellini, Carolina M ^a   Parson, Henri K ^a   Hodges, Kim ^a   Edwards, Joshua F ^a   Lieb, David C ^a   Wohlgemuth, Stephen D ^b   Vinik, Aaron I ^a  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^b Sentara Medical Group   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL PEPTIDASE IV INHIBITOR; GLUCAGON LIKE PEPTIDE 1 DERIVATIVE; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; INCRETIN; INSULIN; METFORMIN; SULFONYLUREA DERIVATIVE; THIAZOLIDINE DERIVATIVE;

ADULT; ARTICLE; AUTONOMIC NERVE; BARIATRIC SURGERY; BODY FAT; BODY MASS; BODY WEIGHT; CLINICAL ASSESSMENT TOOL; COLD INJURY; COLD INTOLERANCE; CONSTIPATION; CONTROLLED STUDY; DIAGNOSTIC KIT; DISEASE ASSOCIATION; DIZZINESS; FATIGUE; FEMALE; FOLLOW UP; FOOT; FREQUENCY ANALYSIS; HAIR LOSS; HAND; HEADACHE; HEART FUNCTION; HEART RATE; HEART RATE VARIABILITY; HOMEOSTASIS; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NAUSEA; NERVE CONDUCTION; NEUROLOGIC IMPAIRMENT SCORES OF LOWER LEGS; NON INSULIN DEPENDENT DIABETES MELLITUS; NUTRITIONAL INTOLERANCE; OBESITY; QUANTITATIVE ANALYSIS; QUANTITATIVE SENSORY TEST; RATING SCALE; ROUX Y ANASTOMOSIS; SCORING SYSTEM; SKIN CONDUCTANCE; SLEEVE GASTRECTOMY; SUDOMOTOR AUTONOMIC C FIBER FUNCTION; SUDORIMETRY; SURAL NERVE; TIME; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT WITHDRAWAL; WAIST CIRCUMFERENCE; AUTONOMIC NERVOUS SYSTEM; COMPLICATION; CONVALESCENCE; HEART; MIDDLE AGED; NERVE FIBER; PATHOPHYSIOLOGY; PHYSIOLOGY; SWEAT GLAND;

ADULT; AUTONOMIC NERVOUS SYSTEM; BARIATRIC SURGERY; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; HEART; HUMANS; MALE; MIDDLE AGED; NERVE FIBERS; OBESITY; RECOVERY OF FUNCTION; SWEAT GLANDS; TREATMENT OUTCOME;

EID: 84969540934     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0154211     Document Type: Article

References (67)

1. Dixon JB, le Roux CW, Rubino F, Zimmet P. Bariatric surgery for type 2 diabetes. Lancet 2012Jun 16; 379(9833):2300-11. doi: 10.1016/S0140-6736(12)60401-2 PMID: 22683132
2. Sjostrom L, Lindroos AK, Peltonen M, Torgerson J, Bouchard C, Carlsson B, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 2004Dec 23; 351 (26):2683-93. PMID: 15616203
3. Carlsson LM, Peltonen M, Ahlin S, Anveden A, Bouchard C, Carlsson B, et al. Bariatric surgery and prevention of type 2 diabetes in Swedish obese subjects. N Engl J Med 2012Aug 23; 367(8):695-704. doi: 10.1056/NEJMoa1112082 PMID: 22913680
4. Sjostrom L, Peltonen M, Jacobson P, Sjostrom CD, Karason K, Wedel H, et al. Bariatric surgery and long-term cardiovascular events. JAMA 2012Jan 4; 307(1):56-65. doi: 10.1001/jama.2011.1914 PMID: 22215166
5. Schauer PR, Kashyap SR, Wolski K, Brethauer SA, Kirwan JP, Pothier CE, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med 2012Apr 26; 366 (17):1567-76. doi: 10.1056/NEJMoa1200225 PMID: 22449319
6. Schauer PR, Bhatt DL, Kirwan JP, Wolski K, Brethauer SA, Navaneethan SD, et al. Bariatric surgery versus intensive medical therapy for diabetes - 3-year outcomes. N Engl J Med 2014May 22; 370 (21):2002-13. doi: 10.1056/NEJMoa1401329 PMID: 24679060
7. Mingrone G, Panunzi S, De GA, Guidone C, Iaconelli A, Leccesi L, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med 2012Apr 26; 366(17):1577-85. doi: 10.1056/NEJMoa1200111 PMID: 22449317
8. Ikramuddin S, Korner J, Lee WJ, Connett JE, Inabnet WB, Billington CJ, et al. Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: the Diabetes Surgery Study randomized clinical trial. JAMA 2013Jun 5; 309(21):2240-9. doi: 10.1001/jama.2013.5835 PMID: 23736733
9. Adams TD, Davidson LE, Litwin SE, Kolotkin RL, Lamonte MJ, Pendleton RC, et al. Health benefits of gastric bypass surgery after 6 years. JAMA 2012Sep 19; 308(11):1122-31. PMID: 22990271
10. Courcoulas AP, Yanovski SZ, Bonds D, Eggerman TL, Horlick M, Staten MA, et al. Long-term outcomes of bariatric surgery: a National Institutes of Health symposium. JAMA Surg 2014Dec; 149 (12):1323-9. doi: 10.1001/jamasurg.2014.2440 PMID: 25271405
11. Courcoulas AP, Goodpaster BH, Eagleton JK, Belle SH, Kalarchian MA, Lang W, et al. Surgical vs medical treatments for type 2 diabetes mellitus: a randomized clinical trial. JAMA Surg 2014Jul; 149 (7):707-15. doi: 10.1001/jamasurg.2014.467 PMID: 24899268
12. Gloy VL, Briel M, Bhatt DL, Kashyap SR, Schauer PR, Mingrone G, et al. Bariatric surgery versus nonsurgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials. BMJ 2013; 347:f5934. doi: 10.1136/bmj.f5934 PMID: 24149519
13. Sjostrom L, Peltonen M, Jacobson P, Ahlin S, Andersson-Assarsson J, Anveden A, et al. Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications. JAMA 2014Jun 11; 311(22):2297-304. doi: 10.1001/jama.2014.5988 PMID: 24915261
14. Courcoulas AP, Belle SH, Neiberg RH, Pierson SK, Eagleton JK, Kalarchian MA, et al. Three-Year Outcomes of Bariatric Surgery vs Lifestyle Intervention for Type 2 Diabetes Mellitus Treatment: A Randomized Clinical Trial. JAMA Surg 2015Oct 1; 150(10):931-40. doi: 10.1001/jamasurg.2015.1534 PMID: 26132586
15. Golomb I, Ben DM, Glass A, Kolitz T, Keidar A. Long-term Metabolic Effects of Laparoscopic Sleeve Gastrectomy. JAMA Surg 2015Aug 5.
16. Madsbad S, Dirksen C, Holst JJ. Mechanisms of changes in glucose metabolism and bodyweight after bariatric surgery. Lancet Diabetes Endocrinol 2014Feb; 2(2):152-64. doi: 10.1016/S2213-8587(13) 70218-3 PMID: 24622719
17. Peterli R, Steinert RE, Woelnerhanssen B, Peters T, Christoffel-Court, Gass M, et al. Metabolic and hormonal changes after laparoscopic Roux-en-Y gastric bypass and sleeve gastrectomy: a randomized, prospective trial. Obes Surg 2012May; 22(5):740-8. doi: 10.1007/s11695-012-0622-3 PMID: 22354457
18. Piestrzeniewicz K, Luczak K, Lelonek M, Wranicz JK, Goch JH. Obesity and heart rate variability in men with myocardial infarction. Cardiol J 2008; 15(1):43-9. PMID: 18651384
19. Straznicky NE, Lambert GW, McGrane MT, Masuo K, Dawood T, Nestel PJ, et al. Weight loss may reverse blunted sympathetic neural responsiveness to glucose ingestion in obese subjects with metabolic syndrome. Diabetes 2009May; 58(5):1126-32. doi: 10.2337/db08-1595 PMID: 19188428
20. Lambert E, Sari CI, Dawood T, Nguyen J, McGrane M, Eikelis N, et al. Sympathetic nervous system activity is associated with obesity-induced subclinical organ damage in young adults. Hypertension 2010Sep; 56(3):351-8. doi: 10.1161/HYPERTENSIONAHA.110.155663 PMID: 20625075
21. Lambert GW, Straznicky NE, Lambert EA, Dixon JB, Schlaich MP. Sympathetic nervous activation in obesity and the metabolic syndrome - causes, consequences and therapeutic implications. Pharmacol Ther 2010May; 126(2):159-72. doi: 10.1016/j.pharmthera.2010.02.002 PMID: 20171982
22. Straznicky NE, Lambert EA, Lambert GW, Masuo K, Esler MD, Nestel PJ. Effects of dietary weight loss on sympathetic activity and cardiac risk factors associated with the metabolic syndrome. J Clin Endocrinol Metab 2005Nov; 90(11):5998-6005. PMID: 16091482
23. Straznicky NE, Eikelis N, Nestel PJ, Dixon JB, Dawood T, Grima MT, et al. Baseline sympathetic nervous system activity predicts dietary weight loss in obese metabolic syndrome subjects. J Clin Endocrinol Metab 2012Feb; 97(2):605-13. doi: 10.1210/jc.2011-2320 PMID: 22090279
24. Ito H, Ohshima A, Tsuzuki M, Ohto N, Yanagawa M, Maruyama T, et al. Effects of increased physical activity and mild calorie restriction on heart rate variability in obese women. Jpn Heart J 2001Jul; 42 (4):459-69. PMID: 11693282
25. Ravussin E. Impact of Six Month Caloric Restriction on Autonomic Nervous System in Healthy, Overweight Individuals. Obesity 2010; 18:414-6. doi: 10.1038/oby.2009.408 PMID: 19910943
26. Ziegler D, Strom A, Nowotny B, Zahiragic L, Nowotny PJ, Carstensen-Kirberg M, et al. Effect of Low-Energy Diets Differing in Fiber, Red Meat, and Coffee Intake on Cardiac Autonomic Function in Obese Individuals With Type 2 Diabetes. Diabetes Care 2015Sep; 38(9):1750-7. doi: 10.2337/dc15-0466 PMID: 26070589
27. Karason K, Molgaard H, Wikstrand J, Sjostrom L. Heart rate variability in obesity and the effect of weight loss. Am J Cardiol 1999Apr 15; 83(8):1242-7. PMID: 10215292
28. Maser RE, Lenhard MJ, Irgau I, Wynn GM. Impact of surgically induced weight loss on cardiovascular autonomic function: one-year follow-up. Obesity (Silver Spring) 2007Feb; 15(2):364-9.
29. Maser RE, Lenhard MJ, Peters MB, Irgau I, Wynn GM. Effects of surgically induced weight loss by Roux-en-Y gastric bypass on cardiovascular autonomic nerve function. Surg Obes Relat Dis 2013Mar; 9(2):221-6. doi: 10.1016/j.soard.2011.11.014 PMID: 22222304
30. Perugini RA, Li Y, Rosenthal L, Gallagher-Dorval K, Kelly JJ, Czerniach DR. Reduced heart rate variability correlates with insulin resistance but not with measures of obesity in population undergoing laparoscopic Roux-en-Y gastric bypass. Surg Obes Relat Dis 2010May; 6(3):237-41. doi: 10.1016/j.soard.2009.09.012 PMID: 20005785
31. Nault I, Nadreau E, Paquet C, Brassard P, Marceau P, Marceau S, et al. Impact of bariatric surgery - induced weight loss on heart rate variability. Metabolism 2007Oct; 56(10):1425-30. PMID: 17884456
32. Lieb DC, Parson HK, Mamikunian G, Vinik AI. Cardiac autonomic imbalance in newly diagnosed and established diabetes is associated with markers of adipose tissue inflammation. Exp Diabetes Res 2012; 2012:878760. doi: 10.1155/2012/878760 PMID: 22110481
33. Wulsin LR, Horn PS, Perry JL, Massaro J, D'Agostino R. Autonomic Imbalance as a Predictor of Metabolic Risks, Cardiovascular Disease, Diabetes, and Mortality Autonomic Imbalance Predicts CVD, DM, Mortality. J Clin Endocrinol Metab 2015Mar 31;jc20144123.
34. Lonn EM, Rambihar S, Gao P, Custodis FF, Sliwa K, Teo KK, et al. Heart rate is associated with increased risk of major cardiovascular events, cardiovascular and all-cause death in patients with stable chronic cardiovascular disease: an analysis of ONTARGET/TRANSCEND. Clin Res Cardiol 2014Feb; 103(2):149-59. doi: 10.1007/s00392-013-0644-4 PMID: 24356937
35. Vinik AI, Ziegler D. Diabetic cardiovascular autonomic neuropathy. Circulation 2007Jan 23; 115 (3):387-97. PMID: 17242296
36. Gibbons CH, Illigens BM, Wang N, Freeman R. Quantification of sweat gland innervation: a clinical-pathologic correlation. Neurology 2009Apr 28; 72(17):1479-86. doi: 10.1212/WNL.0b013e3181a2e8b8 PMID: 19398703
37. Vinik AI, Nevoret M, Casellini C, Parson H. Neurovascular function and sudorimetry in health and disease. Curr Diab Rep 2013Aug; 13(4):517-32. doi: 10.1007/s11892-013-0392-x PMID: 23681491
38. Mayaudon H, Miloche PO, Bauduceau B. A new simple method for assessing sudomotor function: relevance in type 2 diabetes. Diabetes Metab 2010Dec; 36(6 Pt 1):450-4. doi: 10.1016/j.diabet.2010.05.004 PMID: 20739207
39. Gin H, Baudoin R, Raffaitin CH, Rigalleau V, Gonzalez C. Non-invasive and quantitative assessment of sudomotor function for peripheral diabetic neuropathy evaluation. Diabetes Metab 2011Dec; 37 (6):527-32. doi: 10.1016/j.diabet.2011.05.003 PMID: 21715211
40. Calvet JH, Dupin J, Winiecki H, Schwarz PEH. Assessment of Small Fiber Neuropathy through a Quick, Simple and Non Invasive Method in a German Diabetes Outpatient Clinic. Exp Clin Endocrinol Diabetes 2012; 120:1-4.
41. Casellini CM, Parson HK, Richardson MS, Nevoret ML, Vinik AI. Sudoscan, a Noninvasive Tool for Detecting Diabetic Small Fiber Neuropathy and Autonomic Dysfunction. Diabetes Technol Ther 2013Jul 27; 15(11):948-53. doi: 10.1089/dia.2013.0129 PMID: 23889506
42. Freedman BI, Smith SC, Bagwell BM, Xu J, Bowden DW, Divers J. Electrochemical Skin Conductance in Diabetic Kidney Disease. Am J Nephrol 2015; 41(6):438-47. doi: 10.1159/000437342 PMID: 26228248
43. Smith AG, Lessard M, Reyna S, Doudova M, Singleton JR. The diagnostic utility of Sudoscan for distal symmetric peripheral neuropathy. J Diabetes Complications 2014Jul; 28(4):511-6. doi: 10.1016/j.jdiacomp.2014.02.013 PMID: 24661818
44. Luk AO, Fu WC, Li X, Ozaki R, Chung HH, Wong RY, et al. The Clinical Utility of SUDOSCAN in Chronic Kidney Disease in Chinese Patients with Type 2 Diabetes. PLoS One 2015; 10(8):e0134981. doi: 10.1371/journal.pone.0134981 PMID: 26270544
45. Selvarajah D, Cash T, Davies J, Sankar A, Rao G, Grieg M, et al. SUDOSCAN: A Simple, Rapid, and Objective Method with Potential for Screening for Diabetic Peripheral Neuropathy. PLos One 2015; 10 (10):e0138224. doi: 10.1371/journal.pone.0138224 PMID: 26457582
46. Freedman BI, Bowden DW, Smith SC, Xu J, Divers J. Relationships between electrochemical skin conductance and kidney disease in Type 2 diabetes. J Diabetes Complications 2014Jan; 28(1):56-60. doi: 10.1016/j.jdiacomp.2013.09.006 PMID: 24140119
47. Raisanen A, Eklund J, Calvet J- H, Tuomilehto J. Sudomotor function as a tool for cardiorespiratory fitness level evaluation: comparison with VO2 max. Int J Environ Res Public Health 2014; 11 (doi: 10. 3390/ijerph100x000x):5839-48. PMID: 24886754
48. Dyck PJ, Davies JL, Litchy WJ, O'Brien PC. Longitudinal assessment of diabetic polyneuropathy using a composite score in the Rochester Diabetic Neuropathy Study cohort. Neurology 1997Jul; 49(1):229-39. PMID: 9222195
49. Bril V. NIS-LL: the primary measurement scale for clinical trial endpoints in diabetic peripheral neuropathy. Eur Neurol 1999; 41 Suppl 1:8-13:8-13. PMID: 10023123
50. Vinik AI, Erbas T, Park TS. Methods for evaluation of peripheral neurovascular dysfunction. Diabetes Technology and Therapeutics 2001; 3:29-50. PMID: 11469707
51. Lee JA, Halpern EM, Lovblom LE, Yeung E, Bril V, Perkins BA. Reliability and validity of a point-of-care sural nerve conduction device for identification of diabetic neuropathy. PLoS One 2014; 9(1):e86515. doi: 10.1371/journal.pone.0086515 PMID: 24466129
52. Levy JC, Matthews DR, Hermans MP. Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care 1998Dec; 21(12):2191-2. PMID: 9839117
53. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care 2004Jun; 27 (6):1487-95. PMID: 15161807
54. Standards of medical care in diabetes - 2013. Diabetes Care 2013Jan; 36 Suppl 1:S11-S66. doi: 10. 2337/dc13-S011 PMID: 23264422
55. Kassir R, Barthelemy JC, Roche F, Blanc P, Zufferey P, Galusca B, et al. Bariatric surgery associated with percutaneous auricular vagal stimulation: A new prospective treatment on weight loss. Int J Surg 2015Jun; 18:55-6. doi: 10.1016/j.ijsu.2015.04.033 PMID: 25868422
56. Quilliot D, Bohme P, Zannad F, Ziegler O. Sympathetic-leptin relationship in obesity: effect of weight loss. Metabolism 2008Apr; 57(4):555-62. doi: 10.1016/j.metabol.2007.11.020 PMID: 18328360
57. Skrapari I, Tentolouris N, Katsilambros N. Baroreflex function: determinants in healthy subjects and disturbances in diabetes, obesity and metabolic syndrome. Curr Diabetes Rev 2006Aug; 2(3):329-38. PMID: 18220637
58. Wu JM, Yu HJ, Lai HS, Yang PJ, Lin MT, Lai F. Improvement of heart rate variability after decreased insulin resistance after sleeve gastrectomy for morbidly obesity patients. Surg Obes Relat Dis 2015May; 11(3):557-63. doi: 10.1016/j.soard.2014.09.011 PMID: 25630807
59. Lips MA, de Groot GH, De KM, Berends FJ, Wiezer R, Van Wagensveld BA, et al. Autonomic nervous system activity in diabetic and healthy obese female subjects and the effect of distinct weight loss strategies. Eur J Endocrinol 2013Oct; 169(4):383-90. doi: 10.1530/EJE-13-0506 PMID: 23847327
60. Kokkinos A, Alexiadou K, Liaskos C, Argyrakopoulou G, Balla I, Tentolouris N, et al. Improvement in cardiovascular indices after Roux-en-Y gastric bypass or sleeve gastrectomy for morbid obesity. Obes Surg 2013Jan; 23(1):31-8. doi: 10.1007/s11695-012-0743-8 PMID: 22923313
61. Machado MB, Velasco IT, Scalabrini-Neto A. Gastric bypass and cardiac autonomic activity: influence of gender and age. Obes Surg 2009Mar; 19(3):332-8. doi: 10.1007/s11695-008-9665-x PMID: 18719968
62. Bobbioni-Harsch E, Sztajzel J, Barthassat V, Makoundou V, Gastaldi G, Sievert K, et al. Independent evolution of heart autonomic function and insulin sensitivity during weight loss. Obesity (Silver Spring) 2009Feb; 17(2):247-53.
63. Mehrabyan A, Pittenger G, Burcus N, Simmons K, Dublin C. Polyneuropathy in Patients with Dysmetabolic Syndrome and Newly Diagnosed. Diabetes 200453 (Suppl 2):A510.
64. Ziegler D, Low PA, Litchy WJ, Boulton AJ, Vinik AI, Freeman R, et al. Efficacy and safety of antioxidant treatment with alpha-lipoic acid over 4 years in diabetic polyneuropathy: the NATHAN 1 trial. Diabetes Care 2011Sep; 34(9):2054-60. doi: 10.2337/dc11-0503 PMID: 21775755
65. Ziegler D, Low PA, Freeman R, Tritschler H, Vinik AI. Predictors of improvement and progression of diabetic polyneuropathy following treatment with alpha-lipoic acid for 4years in the NATHAN 1 trial. J Diabetes Complications 2016 Mar; 30(2):350-6. doi: 10.1016/j.jdiacomp.2015.10.018 PMID: 26651260
66. Buchwald H, Estok R, Fahrbach K, Banel D, Jensen MD, Pories WJ, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med 2009Mar; 122(3):248-56. doi: 10.1016/j.amjmed.2008.09.041 PMID: 19272486
67. Sjoholm K, Sjostrom E, Carlsson LM, Peltonen M. Weight Change-Adjusted Effects of Gastric Bypass Surgery on Glucose Metabolism: Two- and 10-Year Results From the Swedish Obese Subjects (SOS) Study. Diabetes Care 2015Dec 17.